课题基金 / 基金详情

Implication of RNase H domain on dimer stability and drug sensitivity of HIV-1 RT

Implication of RNase H domain on dimer stability and drug sensitivity of HIV-1 RT
RNase H 结构域对 HIV-1 RT 二聚体稳定性和药物敏感性的影响
批准号:
8541412
负责人:
Virendra Nath PANDEY
金额:
$18.68万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2015-07-31

项目摘要

项目成果

Virendra Nath PANDEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The connection subdomain and RNase H domain of HIV-1 RT have recently been implicated in the emergence of HIV-1 strains that are resistant to NRTI and NNRTI drugs. Site-specific mutations in the connection subdomain and RNase H domain reportedly affect substrate or NRTI binding affinity and other polymerase-related properties such as processivity, suggesting that definitive long-distance cross-talk occurs between the polymerase domain and these two distantly located structural units of HIV-1 RT. Numerous mechanisms, including a reduction in RNase H cleavage activity, which decreased template switching, and improper positioning of template-primer substrate have been proposed to explain the drug-resistant mutations. Based on the three-dimensional (3D) structure of HIV-1 RT, we propose that hydrophobic residues at the C-terminal region of the RNase H domain interacting with the C-terminal connection subdomain may be structurally important in subunit dimerization; any mutational changes in these regions may affect dimer stability and the substrate binding affinity of HIV-1 RT. We propose to investigate the implications of mutations of hydrophobic residues at the interface of the connection subdomain and RNase H domain of HIV-1 RT with respect to dimer stability and drug sensitivity of the enzyme. We will also include clinically relevant drug-resistant mutations that emerge in connection and RNase H under drug pressure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Implication of RNase H domain on dimer stability and drug sensitivity of HIV-1 RT
  • 批准号:
    8707365
  • 项目类别:
  • 资助金额:
    $23.85万
  • 财政年份:
    2013
  • 负责人:
    Virendra Nath PANDEY
  • 依托单位:
FUSE Binding Protein As a Cellular Effector of HCV Replication
FUSE Binding Protein As a Cellular Effector of HCV Replication
Proteomics of HCV Replication Complex
海外基金